Cholera Vaccine Market: Make A Profit & Provide Help to The Needy
Pandemics and endemics have remained an integral part
of the evolution of human civilization. It has been found that almost seven
cholera pandemics have occurred in the past 200 years. Moreover, the seventh
cholera pandemic is officially ongoing pandemic and it has been occurring since
1961. The horrendous Yemen cholera outbreak happened during the year 2016-2021,
which took many lives. In this article we will read about cholera and the
vaccines available in the market. The cholera vaccine market is rising unprecedentedly on the back of rising
awareness regarding cases of the cholera.
What is cholera and
its epidemiology?
The cholera is a serious disease that causes stomach
pains and vomiting. The disease may cause death and it most common in the hot
tropical countries. This disease can be epidemic or endemic and it is estimated
that in year 2020, 323 369 cases and 857 deaths were counted from 24 countries.
To prevent and control cholera and to eradicate deaths, a combination of
strategies has been use by the people such as, combination of surveillance,
water, hygiene, and sanitation, treatment, and oral cholera vaccines are
extensively used. Furthermore, the oral cholera vaccines are giving protection
to the people. Here is the description of oral cholera vaccine.
For More Insights-
https://www.kennethresearch.com/sample-request-10352037
Oral cholera
vaccines-
Currently there are WHO pre-qualified oral cholera
vaccines shanchol, dukoral, and euvichol are three vaccines for cholera
prevention.
-Dukoral
The dukoral is given with a buffer solution, which
means it requires 150 ml of clean water. It can be given to all the individuals
over the age of 2 years. Doctors suggest that a minimum of 7 days and no more
of six weeks of delay between each of the dose. For the children who are 2-5
years old require a third dose. It has been seen that two doses of dukoral
provide complete protection against cholera.
-Shanchol
The shanchol and euvichol plus consist the same
vaccine formula produced by 2 different manufacturers. They do not require a
buffer solution for administration. These vaccines also require buffer solution
for the administration and given to all individuals over the age of 1 year.
Scientists suggest that there must be a minimum of 2 weeks of delay between each
dose of vaccines. The complete two doses of the vaccine Schanchol and Euvichol
plus provide a complete protection against cholera for at least 3 years, while
one dose provide protection for short term.
The Oral Cholera Vaccines be used in the areas having
endemic cholera or high risk of the cholera. Also, the vaccination must not
interrupt the provision of other high priority health interventions to prevent
and control cholera outbreaks. Approximately 100 million doses of oral cholera
vaccines have been used in mass vaccination campaigns. These vaccination
campaigns have been implemented in the areas of high vulnerability during
humanitarian crises. These vaccination campaign are also organized in the
highly endemic areas, which are called “hotspots”.
Moreover, the global road map on controlling the
cholera focuses on 3 stages axes which are written below: -
1-
An early detection and
prompt action to contain the cholera outbreak through an early and rapid
detection.
2-
A well targeted
multi-dimensional approach to eradicate cholera recurrence. The transmission of
cholera can be stopped in these vulnerable areas through measures of mass
vaccination campaign.
3-
Advocacy, technical
support, partnership, and resource mobilization at the global and local levels.
Market Synopsis: -
The cholera vaccine market was holding approximately
USD 65 million, and it is projected to reach USD 207 million by the year 2025,
growing at a CAGR of 16%. Few examples of the key companies are Shantha
Biotechnics, EuBiologics Co., Ltd., Hilleman Laboratories, Sanofi, and others.
In a nutshell,
Comments